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Introduction:  
The use of thrombolytic agent e.g. streptokinase is indicated in patients with 
early acute ST elevation myocardial infarction (MI) (if there are no 
contraindications) is becoming increasingly routine 1. Its use is however 
significantly limited by bleeding complications. Spinal epidural haematoma 
(SEH) is haemorrhage in the spinal epidural space after spinal anaesthesia. 
SEH may be acute or chronic, spontaneous, posttraumatic, or iatrogenic but 
its occurrence appears to be particularly associated with acquired 
coagulopathy from medications and disease states. Patients usually present 
with acute axial spine pain and evolving focal neurological deficits 2. With 
increasing number of available anticoagulants and patient receiving them, 
anaesthesiologists today have to face the challenge of balancing between 
risks and benefits of regional anesthesia in patients under such medications. 
The treatment of this condition involves the principles of conservative follow-
up directed by an improving examination and an understanding of the 
pathophysiology of coagulopathy-induced spontaneous epidural bleeds. 
When the diagnosis is accomplished rapidly, surgical decompression can 
result in full functional recovery 1.  
CASE REPORT 
A 73-year-old, 60-kg man with indirect right inguinal hernia was admitted 
for an elective laparoscopic herniotomy under spinal anaesthesia. He was 
otherwise healthy with preoperative laboratory data, chest X-ray and 
electrocardiogram (ECG) were within normal limits. The premedication 
consisted of tablet midazolam 7.5 mg at night and 7.5 mg orally 2 hours 
before induction of anesthesia. Intraoperative monitoring included an ECG 
(lead II), pulse oximetry and urine output measurement. Spinal anesthesia 
was induced with patient in sitting position at the level L3/L4 intervertebrae 
space using Spinocan needle size 25G. A total of 2.6cc of 0.5% marcaine 
and 25 mg fentanyl were administered into subarachnoid space, following 
which he was positioned supine to facilitate surgical exposure. The 
anesthetic and surgical courses were uneventful for the initial 30 minutes 
until the patient complained of sharp stabbing pain at the surgical site. It 
was followed by a sudden rise in blood pressure (from 120 mm Hg to 190 
mm Hg systolic and 120 mm Hg to 110 mm Hg diastolic) and heart rate 
(from 80 bpm to 140 bpm), but the oxygen saturation was maintained at 
98% to 99%. As a result, the spinal anaesthesia was converted to a general 
anesthesia technique in order to proceed with the operation. The operation 
was uneventful and completed after about 2 hours. At the end of the 
operation, all the anesthetics gases were discontinued and lungs were 
ventilated with 100% oxygen. The reversal process was uneventful but the 
patient became desaturated (SpO2 from 99% to 85%) and EtCO2 increased 
(from 38 mmHg to 67mmHg) after 10 minutes. There was neither history of 
sudden onset of chest pain nor abnormal ECG to account for these changes. 
The patient was then reintubated and sent to intensive care unit (ICU) for 
assisted ventilation and close monitoring. After five hours of assisted 
ventilation, he was weaned off from ventilator and extubated following 
achievement of extubation criteria. Approximately an hour later, he suddenly 
became tachycardia and hypotensive with ST elevation on 12 leads ECG. He 
however did not complain of any chest pain. Anterior myocardial infarction 
was diagnosed, cardiac enzymes were sent and he was started on 
thrombolytic therapy with streptokinase. However, he subsequently 
developed hypotension and thus dobutamine support was instituted. Since 
the patient had already been given subarachnoid (spinal) block, a full dose 
of streptokinase can be dangerous to the patient which might cause spinal 
haematoma, secondary to bleeding tendencies. Therefore, in view of 6 hours 
post spinal anaesthesia, a half dose of streptokinase 750,000 units was 
given to this patient after appropriate discussion between physicians and 
anaesthetists. He was also started on aspirin 300 mg stat and 150 mg orally 
once daily. 2 hours post streptokinase therapy, the ST changes resolved but 
minimal bleeding was noted from the CVP site. There was no back pain or 
lower extremity neurological deficits to suggest spinal cord compression 
secondary to spinal epidural haematoma. He also developed a few episodes 
of atrial fibrillation and supraventricular tachycardia but resolved with 
digoxin and amiodarone. There was no further streptokinase given. He was 
discharged five days later from ICU though requiring dobutamine support 
until 13-post operative day in ward. 
DISCUSSION 
Treatment with reperfusion therapies are associated with increased short- 
and medium term survival after infarction4. Nevertheless, the greatest risk 
of thrombolytic therapy is hemorrhage. Streptokinase (plasminogen 
activators) 1.5 million U infused in 30 to 60 minutes, converts single chain 
plasminogen to double chain plasminogen, which has fibrinolytic activity. 
Thrombolytic therapy is most effective in the first few minutes and hours 
after the onset of MI. During the acute phase of Q-wave MI, thrombolytic 
drugs reduce hospital mortality between 30 and 50%. It does not require 
concomitant heparin therapy. Greatest benefit occurs within 3 hours, but 
effectiveness up to 12 hours has been demonstrated 6. 
The risk of spinal epidural hematoma is low if single puncture was done 
provided no vessel was injured during the procedure but it is considerable if 
multiple puncture is performed and large needle is used. Traumatic insertion 
of the spinal needle is an independent risk factor for epidural hematoma 
formation 8.The risk of spinal epidural hematoma after spinal anaesthesia 
without concomitant antithrombotic medication is 1:200 000 5,9. However, 
with the use of anticoagulant or thrombolytic therapy, the frequency of SEH 
formation is increased 8. The risk is also higher if a patient has low platelet 
(£ 50,000) or history of bleeding tendency. SEH, eventhough rare, is a 
potentially devastating complication 3. The common presentation always 
involves severe axial spine (neck or back) pain with or without neurological 
deficit 2. Others symptoms include muscle weakness, back pain, sensory 
deficit and urinary retention 3. Pain can be aggravated by straining or 
Valsalva maneuver (eg. coughing). Progressive neurological deficit if occur 
can take hours or days to resolve.  
In this case, an acute MI was confirmed by serial ECG recording. As the 
patient had spinal anaesthesia, half dose of streptokinase was given after 
extensive discussion between anaesthetists and physicians to avoid 
possibility of a spinal epidural haematoma formation and at the same time to 
reverse the thrombus formation in the coronary artery. This approach was 
successful where the patient showed improvement in the ST segment 
without any evidence of spinal epidural haematoma.  
Hence, in managing such a case, a high index of suspicious among 
physicians and anaesthetists in-charged regarding this rare hemorrhagic 
complication following thrombolytic therapy is the utmost important, 
particularly in elderly patients 7. A definitive diagnosis of spinal epidural 
haematoma can be made based on imaging studies such as magnetic 
resonance imaging (MRI) which may provide information about the precise 
location and severity of spinal cord compression. In case if SEH occur, 
urgent surgical decompression is generally warranted to preserve 
neurological function 1. The outcome of surgery appears to depend on the 
time between the onset of neurological deficits, the extent of haematoma, 
the severity of neurological deficit and surgery3. The operative approach to 
the haematoma is based on the location of SEH and its extent2. In cases 
where the deficit is minimal or resolving especially after 12 hours, a 
conservative follow up approach with magnetic resonance imaging may be 
warranted.       
CONCLUSIONS:  
Spinal epidural hemorrhage is a rare complication of thrombolytic therapy. It 
is advisable to use lower gauge (e.g. 27G) spinal needle in our practice of 
spinal anaesthesia in order to avoid this complication. In a situation where 
thrombolytic therapy is really indicated after regional anaesthesia, 
administration of half the usual dose of streptokinase may be warranted, 
however it must be accompanied by close observation of any neurological 
deficit which may result from a spinal epidural haematoma formation.  
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